E-cigarettes to Promote Smoking Reduction Among Individuals With Schizophrenia

Completed · Not applicable

Conditions studied: Tobacco Smoking

In brief

The purpose of this study is to assess if access to an electronic nicotine delivery device, or e-cigarette, in addition to nicotine patch (21 mg) can help reduce cigarette smoking among individuals diagnosed with schizophrenia compared to nicotine patch alone.

Key facts

Study ID

NCT02918630

Run by

The University of Texas Health Science Center, Houston

People needed

7

Starts

2016-10-01

Expected to finish

2017-08-01

Last updated by the study team

2018-07-05

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Be diagnosed with schizophrenia
• Be in stable medical condition (DSM-V)
• report smoking ≥10 tobacco cigarettes/day
• present a breath CO ≥10 ppm
• report wanting to reduce their cigarette smoking
• be fluent in English
• have a stable living situation

You may not qualify if…

• be currently pregnant or breastfeeding
• report wanting to quit smoking in the immediate future
• test positive for illicit drugs except THC
• have any illness, medical condition, or use of medications, which in the opinion of the study physicians would preclude safe and/or successful completion of the study

Where it is running

• University of Texas Health Science Center at Houston — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.